Literature DB >> 32576019

The role of ramucirumab and pembrolizumab combination in patients with advanced non-small cell lung cancer, gastroesophageal adenocarcinoma, or urothelial carcinoma.

Jane E Rogers1, Jaffer A Ajani2.   

Abstract

Entities:  

Year:  2020        PMID： 32576019     DOI： 10.21037/cco-20-132

Source DB:  PubMed          Journal:  Chin Clin Oncol        ISSN： 2304-3865


× No keyword cloud information.
  1 in total

1.  Safety and efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients with preexisting antinuclear antibodies: a retrospective cohort study.

Authors:  Dongming Zhang; Yuequan Shi; Xiaoyan Liu; Jia Liu; Yan Xu; Jing Zhao; Wei Zhong; Lukas Käsmann; Taiki Hakozaki; Mariano Provencio; Nobuyuki Horita; Nobuhiko Fukuda; Minjiang Chen; Mengzhao Wang
Journal:  Transl Lung Cancer Res       Date:  2022-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.